Health Canada MDL & MDEL Registration: A Complete Guide for Manufacturers and Stakeholders
Health Canada regulates medical devices under the Food and Drugs Act and the Medical Devices Regulations (MDR). To legally manufacture, import, or distribute medical devices in Canada, companies must hold the appropriate licence:
• Medical Device Licence (MDL) – product-level approval for Class II, III, and IV devices.
• Medical Device Establishment Licence (MDEL) – company-level licence for manufacturers (Class I), importers, and distributors of all device classes.
This article explains the initial registration, amendment requirements, and annual review obligations for both MDL and MDEL holders.
1. Understanding MDL vs. MDEL
Medical Device Licence (MDL)
An MDL is required for Class II, III, and IV devices sold in Canada. It confirms that the device meets safety and effectiveness requirements. Manufacturers must demonstrate compliance with ISO 13485 under MDSAP.
Medical Device Establishment Licence (MDEL)
An MDEL is required for:
• Manufacturers of Class I devices
• Importers and distributors of all device classes
It is a licence for the establishment, not the product. MDEL holders must maintain documented procedures for complaint handling, recalls, distribution records, and mandatory problem reporting.
2. Initial Registration Requirements
2.1 Applying for an MDEL
Applications are submitted electronically via Health Canada’s Medical Devices Online System. The applicant must:
• Provide establishment information (legal name, addresses, contacts)
• Specify regulated activities (manufacture, import, distribute)
• Identify device classes handled
• Describe quality management procedures (complaints, recalls, storage, distribution, training, internal audits)
• List foreign manufacturers (for importers)
• Pay the applicable fee
Supporting documents may include:
• Quality system procedures
• Quality agreements with foreign manufacturers
• Evidence of GMP compliance (e.g., ISO 13485 certificates)
• Organizational charts and device lists
2.2 Applying for an MDL
Manufacturers of Class II–IV devices must submit:
• Device description and intended use
• Evidence of safety and effectiveness
• Risk classification justification
• ISO 13485 (MDSAP) certification
• Labelling and instructions for use
MDL applications are reviewed according to device class, with higher classes requiring more extensive evidence.
3. Amendments and Notifications
3.1 MDEL Amendments
MDEL holders must submit amendments when:
• Changing establishment name or address
• Adding or removing activities (manufacture, import, distribute)
• Adding a new building (requires additional fees)
• Updating foreign manufacturer lists
• Changing senior official or regulatory contact
Health Canada processes amendments under section 48 notifications of the MDR.
3.2 MDL Amendments
MDL amendments are required when:
• Adding new device identifiers
• Changing manufacturing sites
• Updating design, materials, or intended use
• Modifying risk classification
Fees apply for MDL amendments under the Fees in Respect of Drugs and Medical Devices Order.
4. Annual Licence Review (ALR)
4.1 MDEL Annual Review
All MDEL holders must submit an Annual Licence Review (ALR) before April 1 each year to maintain their licence. The ALR ensures that:
• Establishment information is current
• Activities remain compliant
• Fees are paid
Failure to submit the ALR results in automatic licence cancellation.
What the ALR includes
• Confirmation of establishment details
• Updated lists of manufacturers and device types
• Confirmation of quality system procedures
• Payment of annual review fees
Fees
Annual review fees are set under the Fees in Respect of Drugs and Medical Devices Order, adjusted annually (e.g., 2.7% CPI increase for 2025–2026). Small businesses may qualify for fee reductions.
4.2 MDL Annual Right-to-Sell Fees
Manufacturers holding MDLs must pay annual right-to-sell fees to maintain authorization for Class II–IV devices. These fees are separate from MDEL ALR fees.
5. Compliance Responsibilities for Licence Holders
MDEL Holders Must Maintain:
• Complaint handling procedures
• Recall procedures
• Distribution records
• Mandatory problem reporting
• Document control and training
• Storage and transportation controls
MDL Holders Must Maintain:
• Post-market surveillance
• Adverse event reporting
• Quality system compliance (ISO 13485/MDSAP)
• Device labelling and safety updates
6. Practical Tips for Manufacturers and Stakeholders
• Confirm device classification early using MDALL to avoid incorrect submissions.
• Maintain up-to-date quality procedures—Health Canada may request them during review.
• Track all foreign manufacturers if you are an importer.
• Prepare for annual fee increases tied to CPI.
• Use small business fee reductions if eligible.
• Submit amendments promptly to avoid compliance gaps.
Conclusion
Navigating Health Canada’s MDL and MDEL requirements is essential for legal market access in Canada. Manufacturers, importers, and distributors must understand the distinctions between product licensing (MDL) and establishment licensing (MDEL), maintain compliant quality systems, and meet annual review obligations. With proper preparation and timely submissions, companies can ensure uninterrupted operations and regulatory compliance in the Canadian medical device market.